Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
WAP four-disulfide core domain protein 13 (WFDC13) is a member of the WFDC (whey acidic protein four-disulfide core) domain family, characterized by a 40–50 amino acid domain that contains eight conserved cysteine residues forming four intramolecular disulfide bonds. The WFDC domain is primarily a structural protein motif with probable function as a protease inhibitor, especially antiprotease activity against serine proteases, although direct biochemical function for WFDC13 has not been fully established and remains putative. Most genes in the WFDC family are clustered on human chromosome 20q12-q13, with WFDC13 located in the telomeric cluster. WFDC proteins in general are implicated in host defense, immune regulation, and inhibition of various proteases, potentially relevant to tissue protection, inflammation, and antimicrobial activity, but no direct links for WFDC13 with specific diseases, biomarkers, or drug interactions are established in current public databases or literature. WFDC13 is referenced as a putative acid-stable proteinase inhibitor, but its precise biological function, disease association, and value as a therapeutic target are unconfirmed. Key contextual notes: - No evidence WFDC13 is currently a direct therapeutic target, receptor, or enzyme of drug interest. - No approved drugs or ligands, no direct safety concerns, and no established role in disease have been assigned in searched biomedical resources. - The structural domain is well described, but specific molecular and clinical relevance remains under-characterized in the literature.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on WAP four-disulfide core domain protein 13 (WFDC13).